Your cart
There are no more items in your cart
DEXYANE MeD PALPEBRAL treats atopic and contact eczema lesions and limits their recurrence.
Its "ultra-hydrating dressing effect" immediately soothes, decongests and protects the skin.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions.
Ultra-hydrating dressing-effect texture:
- instantly relieves and decongests
- soothes itching and pain, reduces redness and irritations.
- restores the skin barrier
- limits bacterial adhesion
Dexyane MeD Palpebral can be used as stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids. Its efficacy has been clinically proven.
Results:
- Immediately reduces itching (1)
- At day 3, significant improvement and even complete disappearance of clinical signs, particularly burning sensations.(1)
(1) Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. Dexyane MeD was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. (2) The overall development of lesions was evaluated by the PGA score on a 5-point scale: 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
Dexyane MeD Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE 0459 mark.
Not to be used by pregnant or breastfeeding women.
Avoid all direct contact with eyes.
Ages 3 months and up.
15ml
10105553
Tap to zoom
